OTCMKTS:FSNUY

Fresenius SE & Co. KGaA Stock Forecast, Price & News

$11.95

-0.15 (-1.24 %)

(As of 09/17/2021 12:00 AM ET)

Add

Compare

Today's Range

$11.95

▼

$12.15

50-Day Range

$11.95

▼

$13.91

52-Week Range

$9.17

▼

$14.81

Volume28,338 shs

Average Volume24,524 shs

Market Capitalization$26.59 billion

P/E Ratio12.85

Dividend Yield1.49%

Beta1.36

30 days | 90 days | 365 days | Advanced Chart

Receive FSNUY News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises of dialysis products and healthcare services. The Fresenius Kabi segment specializes in intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Given Overweight Rating at Barclays
September 10, 2021 | americanbankingnews.com

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Receives Consensus Recommendation of "Buy" from Analysts
September 7, 2021 | americanbankingnews.com

Short Interest in Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Rises By 145.9%
August 27, 2021 | americanbankingnews.com

Parenteral Nutrition Market to Eyewitness Huge Growth by 2027 | Grifols, Pfizer, Baxter International, Fresenius
June 28, 2021 | marketwatch.com

Disposable Blood Transfusion Bag Market 2021 Global Industry Analysis by Trends, Size, Share, Company Overview and Growth Forecast to 2026
June 1, 2021 | marketwatch.com

Fresenius Q1 Net Income Before Special Items Declines; Confirms FY21 Guidance
May 6, 2021 | nasdaq.com

Total Fluid Management Market Size 2021 Research Report including Industry Segment by Type, Historical Data and Market Forecast to 2026 - MarketWatch
April 16, 2021 | marketwatch.com

COMMERZBANK AG (London Branch) - Pre Stabilisation - Fresenius EUR 3 Tranche
March 23, 2021 | uk.finance.yahoo.com

Is FRESENIUS SE&CO (FSNUY) a Great Value Stock Right Now?
February 8, 2021 | finance.yahoo.com

Are Investors Undervaluing Fresenius (FMS) Right Now?
December 30, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:FSNUY
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.fresenius.com
Phone(496) 172-6080
Employees311,269
Year Founded1912

Sales & Book Value

Annual Sales$41.44 billion
Price / Sales0.64
Cash Flow$2.28 per share
Price / Cash Flow5.23
Book Value$13.36 per share
Price / Book0.89

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares2,225,290,000
Market Cap$26.59 billion
Next Earnings Date11/4/2021 (Estimated)
OptionableNot Optionable

Social Links

MarketRank^™

Overall MarketRank^™

2.62 out of 5 stars

3.3 Analyst's Opinion

Consensus Rating
Fresenius SE & Co. KGaA has received a consensus rating of Buy. The company's average rating score is 2.64, and is based on 7 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $13.36, Fresenius SE & Co. KGaA has a forecasted upside of 11.8% from its current price of $11.95.
Amount of Analyst Coverage
Fresenius SE & Co. KGaA has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

4.1 Community Rank

Outperform Votes
Fresenius SE & Co. KGaA has received 188 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Fresenius SE & Co. KGaA has received 111 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Fresenius SE & Co. KGaA has received 62.88% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Fresenius SE & Co. KGaA and other stocks. Vote “Outperform” if you believe FSNUY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FSNUY will underperform the S&P 500 over the long term. You may vote once every thirty days.

2.5 Dividend Strength

Dividend Yield
Fresenius SE & Co. KGaA pays a meaningful dividend of 1.49%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Fresenius SE & Co. KGaA does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Fresenius SE & Co. KGaA is 19.57%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Fresenius SE & Co. KGaA will have a dividend payout ratio of 16.82% next year. This indicates that Fresenius SE & Co. KGaA will be able to sustain or increase its dividend.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Fresenius SE & Co. KGaA insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.06% of the stock of Fresenius SE & Co. KGaA is held by institutions.

3.1 Earnings and Valuation

Earnings Growth
Earnings for Fresenius SE & Co. KGaA are expected to grow by 11.46% in the coming year, from $0.96 to $1.07 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Fresenius SE & Co. KGaA is 12.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 14.50.
Price to Earnings Ratio vs. Sector
The P/E ratio of Fresenius SE & Co. KGaA is 12.85, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.02.
Price to Book Value per Share Ratio
Fresenius SE & Co. KGaA has a P/B Ratio of 0.89. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Frequently Asked Questions

Is Fresenius SE & Co. KGaA a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Fresenius SE & Co. KGaA stock.
View analyst ratings for Fresenius SE & Co. KGaA or view top-rated stocks.

What stocks does MarketBeat like better than Fresenius SE & Co. KGaA?

Wall Street analysts have given Fresenius SE & Co. KGaA a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Fresenius SE & Co. KGaA wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA saw a increase in short interest in the month of August. As of August 13th, there was short interest totaling 36,400 shares, an increase of 145.9% from the July 29th total of 14,800 shares. Based on an average daily volume of 36,800 shares, the days-to-cover ratio is currently 1.0 days.
View Fresenius SE & Co. KGaA's Short Interest.

When is Fresenius SE & Co. KGaA's next earnings date?

Fresenius SE & Co. KGaA is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Fresenius SE & Co. KGaA.

How were Fresenius SE & Co. KGaA's earnings last quarter?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) issued its earnings results on Friday, July, 30th. The company reported $0.26 earnings per share for the quarter. The business earned $11.14 billion during the quarter. Fresenius SE & Co. KGaA had a trailing twelve-month return on equity of 6.98% and a net margin of 4.78%.
View Fresenius SE & Co. KGaA's earnings history.

How has Fresenius SE & Co. KGaA's stock price been impacted by COVID-19 (Coronavirus)?

Fresenius SE & Co. KGaA's stock was trading at $10.13 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, FSNUY stock has increased by 18.0% and is now trading at $11.95.
View which stocks have been most impacted by COVID-19.

How often does Fresenius SE & Co. KGaA pay dividends? What is the dividend yield for Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA announced a dividend on Wednesday, May 19th. Shareholders of record on Tuesday, May 25th will be paid a dividend of $0.5164 per share on Thursday, June 3rd. This represents a yield of 3.76%. The ex-dividend date of this dividend is Monday, May 24th.
View Fresenius SE & Co. KGaA's dividend history.

Is Fresenius SE & Co. KGaA a good dividend stock?

Fresenius SE & Co. KGaA pays an annual dividend of $0.18 per share and currently has a dividend yield of 1.49%. The dividend payout ratio of Fresenius SE & Co. KGaA is 19.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Fresenius SE & Co. KGaA will have a dividend payout ratio of 16.82% next year. This indicates that Fresenius SE & Co. KGaA will be able to sustain or increase its dividend.
View Fresenius SE & Co. KGaA's dividend history.

What price target have analysts set for FSNUY?

11 Wall Street analysts have issued 1 year price objectives for Fresenius SE & Co. KGaA's shares. Their forecasts range from $13.36 to $13.36. On average, they anticipate Fresenius SE & Co. KGaA's stock price to reach $13.36 in the next year. This suggests a possible upside of 11.8% from the stock's current price.
View analysts' price targets for Fresenius SE & Co. KGaA or view top-rated stocks among Wall Street analysts.

Who are Fresenius SE & Co. KGaA's key executives?

Fresenius SE & Co. KGaA's management team includes the following people:

Stephan Sturm, President & Chief Executive Officer
Rachel Clare Empey, Chief Financial Officer
Sebastian Biedenkopf, Legal, Compliance & Human Resources Director
Rice Powell, Chief Executive Officer-Fresenius Medical Care
Francesco De Meo, Chief Executive Officer-Fresenius Helios

Who are some of Fresenius SE & Co. KGaA's key competitors?

Some companies that are related to Fresenius SE & Co. KGaA include 3M (MMM), Stryker (SYK), Becton, Dickinson and (BDX), Boston Scientific (BSX), DexCom (DXCM), Baxter International (BAX), ResMed (RMD), Insulet (PODD), Teleflex (TFX), Abiomed (ABMD), NovoCure (NVCR), Penumbra (PEN), Hill-Rom (HRC), Globus Medical (GMED) and ShockWave Medical (SWAV).
View all of FSNUY's competitors.

What is Fresenius SE & Co. KGaA's stock symbol?

Fresenius SE & Co. KGaA trades on the OTCMKTS under the ticker symbol "FSNUY."

How do I buy shares of Fresenius SE & Co. KGaA?

Shares of FSNUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius SE & Co. KGaA's stock price today?

One share of FSNUY stock can currently be purchased for approximately $11.95.

How much money does Fresenius SE & Co. KGaA make?

Fresenius SE & Co. KGaA has a market capitalization of $26.59 billion and generates $41.44 billion in revenue each year. The company earns $1.95 billion in net income (profit) each year or $0.92 on an earnings per share basis.

How many employees does Fresenius SE & Co. KGaA have?

Fresenius SE & Co. KGaA employs 311,269 workers across the globe.

When was Fresenius SE & Co. KGaA founded?

Fresenius SE & Co. KGaA was founded in 1912.

What is Fresenius SE & Co. KGaA's official website?

The official website for Fresenius SE & Co. KGaA is www.fresenius.com.

Where are Fresenius SE & Co. KGaA's headquarters?

Fresenius SE & Co. KGaA is headquartered at Else-Kroner-Strasse 1, Bad Homburg 2M, 61352.

How can I contact Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The company can be reached via phone at (496) 172-6080 or via email at [email protected]

This page was last updated on 9/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here